지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2017.6
- 수록면
- 10 - 24 (15page)
이용수
초록· 키워드
오류제보하기
Purpose: Annually 27,855 patients in Korea develop treatment-induced mucositis nearly doubling the cost of cancer care. It is an emergency medical condition causing unplanned treatment breaks in 4,998 patients. The subsequent reduction in optimal dose-intensity causes premature deaths due to lower 5-year survival. An additional 216 patients die from mucositis-mediated sepsis and infection. Thus complete elimination of mucositis will immediately reduce the cost of care while simultaneously eliminating 5,214 mucositis-associated deaths. High potency polymerized cross-linked sucralfate (HPPCLS) cleared by the US Food and Drug Administration has been associated with the elimination of mucositis.
Methods: Observational, self-reporting, practice-based mucositis registry. Inclusion criteria: any patient with chemoradiation-induced mucositis. Exclusion criteria: previous adverse reaction to sucralfate products. Primary outcome: rapid reversal or complete prevention. Conduct of study: 28 radiation oncologists from 21 different institutions prescribed HPPCLS to 55 patients undergoing chemoradiation for squamous cell carcinoma of head and neck and esophagus to eliminate mucositis-associated treatment breaks.
Results: All patients with World Health Organization grade 1 (n=6), grade 2 (n=23), grade 3 (n=16) oral mucositis, and grade 2 esophageal mucositis (n=2) experienced complete reversal of mucositis. Within 2–3 days both mucosa and swallowing normalized. Anticipated grade 3/4 mucositis was prevented in 8 out of 8 elderly patients aged 78–93 avoiding gastrostomy tube placement. Statistical analysis of outcomes: Outcomes qualified as a positive Glasziou treatment effect that was statistically significant (P<0.05).
Conclusion: HPPCLS eliminated mucositis by rapid reversal or complete prevention, thereby eliminating unplanned treatment breaks. It may likely reduce mucositis-associated increased cost of care and premature deaths.
Methods: Observational, self-reporting, practice-based mucositis registry. Inclusion criteria: any patient with chemoradiation-induced mucositis. Exclusion criteria: previous adverse reaction to sucralfate products. Primary outcome: rapid reversal or complete prevention. Conduct of study: 28 radiation oncologists from 21 different institutions prescribed HPPCLS to 55 patients undergoing chemoradiation for squamous cell carcinoma of head and neck and esophagus to eliminate mucositis-associated treatment breaks.
Results: All patients with World Health Organization grade 1 (n=6), grade 2 (n=23), grade 3 (n=16) oral mucositis, and grade 2 esophageal mucositis (n=2) experienced complete reversal of mucositis. Within 2–3 days both mucosa and swallowing normalized. Anticipated grade 3/4 mucositis was prevented in 8 out of 8 elderly patients aged 78–93 avoiding gastrostomy tube placement. Statistical analysis of outcomes: Outcomes qualified as a positive Glasziou treatment effect that was statistically significant (P<0.05).
Conclusion: HPPCLS eliminated mucositis by rapid reversal or complete prevention, thereby eliminating unplanned treatment breaks. It may likely reduce mucositis-associated increased cost of care and premature deaths.
목차
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Actual duration of patient-reported mucositis: Far longer than 2 to 4 weeks and may be avoidable altogether
KOREAN JOURNAL OF CLINICAL ONCOLOGY
2016 .06
-
Oral Health Status and Oral Health-related Quality of Life According to Presence or Absence of Mucositis in Head and Neck Cancer Patients
대한암예방학회지
2019 .01
-
구강건강과 두경부 방사선 항암치료에 따른 구강 점막염간의 상관성에 관한 연구
대한구강보건학회지
2018 .06
-
Clinical Efficacy of Coptidis Rhizoma for Non-alcoholic Fatty Liver Disease: A Systematic Review
대한한의학회지
2022 .12
-
Decade Long Survey of Low-level Laser Therapy/ Photobiomodulation (LLLT/PBM) Therapy for Oral Mucositis Treatment
MEDICAL LASERS
2021 .09
-
Protective effect of Yeoldahanso-tang on radiation-induced oral mucositis in mice
대한동의병리학회 학술대회논문집
2015 .10
-
Randomized Double-Blind Placebo-Controlled Trial of Propolis for Oral Mucositis in Patients Receiving Chemotherapy for Head and Neck Cancer
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Protective Effects of N-Acetylcysteine against Radiation-Induced Oral Mucositis In Vitro and In Vivo
Cancer Research and Treatment
2020 .01
-
Methotrexate-induced Oral Mucositis
Journal of Oral Medicine and Pain
2015 .06
-
Oral health management of a patient with tuberous sclerosis complex for oral mucositis under everolimus: A case report
International Journal of Disability and Oral Health
2020 .06
-
Risk indicators for mucositis and peri-implantitis: results from a practice-based cross-sectional study
Journal of Periodontal & Implant Science
2020 .01
-
구강냉요법이 항암화학요법을 받는 유방암 환자의 오심·구토, 구내염, 구강통증에 미치는 효과
Asian Oncology Nursing
2020 .09
-
Safety and Efficacy of a Mouth-Rinse with Granulocyte Colony Stimulating Factor in Patients with Chemotherapy-Induced Oral Mucositis
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
조혈모세포이식에서 구강 점막염 감소를 위한 구강 얼음요법의 효과 : 체계적 문헌고찰과 메타분석
성인간호학회지
2018 .08
-
두경부 영역의 방사선치료와 그에 따른 정상조직 변화
대한연하장애학회지
2018 .01
-
Development of a standardized mucositis and osteoradionecrosis animal model using external radiation
대한구강악안면외과학회지
2020 .08
-
Efficacy of parenteral glutamine supplementation in adult hematopoietic stem cell transplantation patients
Blood Research
2019 .01
-
구강관리 프로토콜 적용이 항암화학요법을 받는 혈액암 환자의 구내염에 미치는 영향
임상간호연구
2016 .01
-
Concurrent Chemoradiation with Weekly Cisplatin for the Treatment of Head and Neck Cancers: an Institutional Study on Acute Toxicity and Response to Treatment
Asian Pacific journal of cancer prevention : APJCP
2015 .01
-
Prevalence and risk factors of peri-implant mucositis and peri-implantitis after at least 7 years of loading
Journal of Periodontal & Implant Science
2019 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0